Dublin, Jan. 26, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/xs4hnp/autoinjectors_to) has announced the addition of the "Autoinjectors to 2024" report to their offering.
Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by the introduction and evolution of autoinjectors - devices that are designed to accept a standard prefilled syringe and form an outer user-friendly device package that simplifies the injection process. Autoinjectors enable a significantly larger segment of the patient population to self-administer injectables. This report analyzes eleven important therapeutic segments and examines the impact of autoinjectors on injectable drug markets.
What You Will Learn
- What autoinjectors can be paired with prefilled syringes for injectable drug delivery; what are the key market segments, market dynamics and market demographics?
- What are the therapeutic demand drivers and commercial devices in key product segments?
- What are the design factors, material selection issues, technologies and market development issues?
- How big is the market? How is it growing? What will it look like in 2024?
- Who are the leading injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations?
- What is the importance of pharma-device alliances and design partnerships on autoinjector commercialization and market access?
- What is the impact of wirelessly connected autoinjectors on patient care and market growth?
- What are the significant economic, technology, and regulatory factors affecting the market for autoinjectors?
Key Topics Covered:
1. Executive Summary
2. The Market Opportunity
3. Delivery Market Dynamics
- The Economics of Injectable Drugs
- What's Driving the Growth in Autoinjectors?
- Prefilled Devices Proliferating
- The Trend toward Self-Administration
- Shifting Demographics
- Innovation in Disposable Device Designs
- Therapeutic Demand Drivers
- Competitive Landscape
- Risk Factors
4. Autoinjectors - Commercial Devices
- Manual Injection Autoinjectors
- Automated Injection Autoinjectors
- Reusable Autoinjectors
- Disposable Autoinjectors
- Variable Dose Autoinjectors
- Smart Autoinjectors
- Product Specific Autoinjectors
5. Autoinjector Device Design Factors
- Material Selection Issues
- Part Counts and Device Cost
- Safety Features
- Needle Insertion Depth
- Dose Inspection/Injection Confirmation
- Wireless Connectivity
- Lyophilized Drugs/Reconstitution
- Human Engineering/Ergonomics
6. Autoinjector Drug Delivery - Therapeutic Sector Analysis
- Anaphylaxis/Countermeasures
- Anticoagulants
- Autoimmune Diseases
- Emergency Medicine
- Infectious Diseases
- Hematopoietics
- Hormones
- Neurology
- Reproductive Health
7. Market Factors
- Regulatory Issues
- Device Branding
- Patient Compliance and Ease of Use
- Healthcare Economics
8. Company Profiles
For more information visit http://www.researchandmarkets.com/research/xs4hnp/autoinjectors_to
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside
Sodexo Unveils Shift & Grow 2030 Strategy, Targets Over 5% Revenue Growth by Fiscal 2030
UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom
NY Times Challenges Trump Administration Subpoenas Over Air Force One Report
Apple Intelligence China Approval Lifts Alibaba and Baidu Shares
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback
United Airlines Beats Q2 Earnings, Raises 2026 Profit Outlook Despite Higher Fuel Costs
Airbus Signs Cloud Deal With Scaleway to Power Secure AI and Defense Applications
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
Volkswagen Launches €28,000 ID. Cross EV as Europe’s Electric Vehicle Demand Accelerates 



